|
RNF7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.594310E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.219300E-03 |
| Normal-vs-Stage2 |
1.306620E-01 |
| Normal-vs-Stage3 |
3.104200E-02 |
| Normal-vs-Stage4 |
2.043200E-01 |
| Stage1-vs-Stage2 |
6.545600E-01 |
| Stage1-vs-Stage3 |
3.600600E-01 |
| Stage1-vs-Stage4 |
3.986600E-01 |
| Stage2-vs-Stage3 |
9.049400E-01 |
| Stage2-vs-Stage4 |
5.322000E-01 |
| Stage3-vs-Stage4 |
5.561400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.035400E-04 |
| Normal-vs-AfricanAmerican |
9.719000E-03 |
| Normal-vs-Asian |
1.446370E-02 |
| Caucasian-vs-AfricanAmerican |
7.037400E-01 |
| Caucasian-vs-Asian |
7.221800E-01 |
| AfricanAmerican-vs-Asian |
5.784200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.344060E-03 |
| Normal-vs-Female |
3.030200E-04 |
| Male-vs-Female |
1.025030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.332000E-02 |
| Normal-vs-Extreme_Weight |
1.023340E-03 |
| Normal-vs-Obese |
4.375800E-02 |
| Normal-vs-Extreme_Obese |
1.713370E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.951400E-01 |
| Normal_Weight-vs-Obese |
4.325000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.538000E-01 |
| Extreme_Weight-vs-Obese |
1.721580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.781200E-01 |
| Obese-vs-Extreme_Obese |
3.646800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.156320E-02 |
| Normal-vs-Age(41-60Yrs) |
7.974900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.122100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.240200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.211200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.536600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.355800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.117800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.200800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.747000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.15830000000517E-07 |
| Normal-VS-Type2 PRCC |
5.599600E-01 |
| Normal-VS-KIRP CIMP |
6.226400E-02 |
| Normal-VS-Unclassified PRCC |
6.601600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.999100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.624600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.016300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.900000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.585000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.926200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.484400E-02 |
| Normal-vs-N1 |
5.422500E-03 |
| Normal-vs-N2 |
4.699400E-01 |
| N0-vs-N1 |
1.712450E-01 |
| N0-vs-N2 |
5.615000E-01 |
| N1-vs-N2 |
6.872200E-01 |
|
|
